Evidence map›Paper›PMID 25653924›Full record

ReviewFrontiers in cellular and infection microbiology2014

Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate?

Claire-Lise Forestier, Qi Gao, Geert-Jan Boons

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Article
  3. Next-generation molecular tools in veterinary parasitology: advances, challenges, and perspectives in the diagnosis of emerging parasites.Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria · 2026
    Review
  4. Article
  5. Free GPIs and Comparison of GPI Structures Among Species.International journal of molecular sciences · 2025
    Review
  6. Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Review
  7. Article
  8. Review
  9. Journal of fungi (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in immunology · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Intra-Specific Diversity ofMicroorganisms · 2022
    Article
  19. Frontiers in cellular and infection microbiology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Claire-Lise ForestierINSERM U1095, Faculté de Médecine, University of Aix-Marseille Marseille, France.
Qi GaoComplex Carbohydrate Research Center, Department of Chemistry, University of Georgia Athens, GA, USA.
Geert-Jan BoonsComplex Carbohydrate Research Center, Department of Chemistry, University of Georgia Athens, GA, USA.
University of Georgia · USInserm · FR

Funding

Synthetic Oligosaccharides for Probing Infection and Innate ImmunityR01GM061761 · NIGMS · UNIVERSITY OF GEORGIA (UGA) · PI BOONS, GEERT-JAN · 2000 to 2014
$4.5M
NIGMS NIH HHS R01 GM061761NIGMS NIH HHS R01GM061761
6 · The paper itself

Abstract

A key feature of many pathogenic microorganisms is the presence of a dense glycocalyx at their surface, composed of lipid-anchored glycoproteins and non-protein-bound polysaccharides. These surface glycolipids are important virulence factors for bacterial, fungal and protozoan pathogens. The highly complex glycoconjugate lipophosphoglycan (LPG) is one of the dominant surface macromolecules of the promastigote stage of all Leishmania parasitic species. LPG plays critical pleiotropic roles in parasite survival and infectivity in both the sandfly vector and the mammalian host. Here, we review the composition of the Leishmania glycocalyx, the chemical structure of LPG and what is currently known about its effects in the mammalian host, specifically. We will then discuss the current approaches employed to elucidate LPG functions. Finally, we will provide a viewpoint on future directions that this area of investigation could take to unravel in detail the biological activity of the specific molecular elements composing the structurally complex LPG.

Indexed as

AnimalsGlycosphingolipidsHumansLeishmaniaLeishmaniasisStructure-Activity RelationshipGlycosphingolipidslipophosphonoglycanchemical synthesisLeishmania glycoconjugateslipophosphoglycanLPG functionLPG structureLPG structure-activity relationships

Identifiers

PMID25653924
PMCPMC4301024
OpenAlexW2082875761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.